logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > Chemical Intermediates > Acetohydroxamic Acid CAS 546-88-3 EINECS NO 208-913-8

Acetohydroxamic Acid CAS 546-88-3 EINECS NO 208-913-8

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 546-88-3

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Bag,Drum

Delivery Time: 7-15 days

Payment Terms: L/C, D/A, T/T, Western Union

Supply Ability: TON

Get Best Price
Highlight:

CAS 546-88-3 Acetohydroxamic Acid

,

CAS 546-88-3

CAS NO::
546-88-3
Appearance::
White Crystalline Solid
Molecular Formula::
C2H5NO2
Molecular Weight::
75.06660
EINECS NO::
208-913-8
MDL NO::
MFCD00009994
CAS NO::
546-88-3
Appearance::
White Crystalline Solid
Molecular Formula::
C2H5NO2
Molecular Weight::
75.06660
EINECS NO::
208-913-8
MDL NO::
MFCD00009994
Acetohydroxamic Acid CAS 546-88-3 EINECS NO 208-913-8

Product Description:

Product Name: Acetohydroxamic acid CAS NO: 546-88-3

 

 

Synonyms:

methanecarbohydroxamic acid;

N-acetylhydroxylamine;

 

 

Chemical & Physical Properties:

Appearance: White Crystalline Solid

Assay :≥99.0%

Density: 1.155g/cm3

Boiling Point: 231.4℃ at 760 mmHg

Melting Point: 86-90℃

Refractive Index: 1.42

Water Solubility: Soluble in water.

Sensitive: Hygroscopic

Stability: Stable under normal temperatures and pressures.

Storage Condition: Store in a cool, dry place. Store in a tightly closed container.

 

 

Safety Information:

RTECS: AK8157000

Safety Statements: S45-S53

HS Code: 2942000000

WGK Germany: 3

Packing Group: II

RIDADR: 3263

Risk Statement: R61

Hazard Code: T

 

 

A urease inhibitor. Used in the synthesis of pyrogallol and catechol derivatives as Helicobacter pylori urease inhibitors. Acetohydroxamic acid is a potent, non-competitive and irreversible inhibitor of bacterial urease (Ki≈lO-7M). This enzyme, which is widely distributed in plants and bacteria, but not in mammalian cells, catalyzes the decomposition of urea to ammonia. Elevated urinary ammonia levels can reduce the antibacterial effectiveness of a number of agents. Thus, acetohydroxamic acid is useful as adjunctive therapy to decrease urinary ammonia and alkalinity in patients with chronic urea-splitting urinary infection. Such infections are a leading cause of recurring complications and death in paraplegics.

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.